PRESS RELEASE: Life Sciences Ireland Workshop: Anti – Counterfeit: How to Protect your Supply Chain

(25 Jul 2013)

New Picture  122  Thumbnail0

PRESS RELEASE: Life Sciences Ireland Workshop: Anti – Counterfeit: How to Protect your Supply Chain

25th July 2013

IEA Life Sciences Ireland recently hosted an Anti-Counterfeit Workshop, Anti – Counterfeit: How to Protect your Supply Chain.   This workshop was run under the Ireland Wales EU Interreg Programme, open to Irish SMEs and attracted more than 15 companies to attend and improve their knowledge and expertise on Security of Supply and Patient Safety through Good Distribution Practice.  
The key learning objectives of this workshop included:  principles of assuring patient safety, principles of supply chain integrity for maintaining product quality, important aspects of the falsified medicines directive 2011/62/EU, global impact of counterfeiting and falsification on patient safety, importance of good manufacturing and good distribution practices, quality systems and traceability and preventing counterfeiting and the countermeasures.

Dr. Niall Stobie, Life Sciences Ireland Manager said, “Working in close consultation with our external steering committee and technical evaluation panel including the Irish Medicines Board, Pfizer, Allergan, Boston Scientific, MSD, Helsinn, GS1 and NITL DIT, the Irish Exporters Association are able to deliver a suite of supply chain training modules for the Life Sciences sector. The overall goal of these training modules is to improve patient safety along the supply chain through a combination of blended online and classroom training modules.   The reason why this training is so relevant now is due to the Falsified Medicines Directive and Good Distribution Practice [GDP] Guidelines released from the EU in 2013 – both focused on driving patient safety in the supply chain.
Participant Norman Barry, Jenkinson Logistics said, “The content was extremely informative, especially when it came to explaining the risk to patient safety.  It also was explained the need for vigilance along the entire supply chain very clearly.  I particularly noted the spread of emphasise on different aspects, such as packaging, transfer points and trading.  The counter-measure explanations were detailed, covering both the current and future solutions.  I was very happy to understand that these strategies are so advanced.   The sooner people in the Life Sciences Industry attend this seminar the better.

For more information on Life Sciences contact:
Dr. Niall Stobie

New Picture  123  Thumbnail0

© 2024 National Institute for Transport & Logistics

  • Technological University Dublin City Campus Bolton Street Dublin 1
  • Phone: +353 1 4023898
  • Fax:
  • Email:


Search - Use spaces to seperate your keywords